On May 29, 2025, Femasys Inc. announced an underwritten offering of 3.6 million shares at $0.85 each, with expected net proceeds of approximately $4.2 million for product development and expansion. Additionally, a private placement involves the sale of around 1.6 million shares at $0.85, alongside a $10 million equity line of credit agreement planned by June 30, 2025.